What Researchers Did
Researchers described a case of severe visual loss and eye pain in a patient who developed iatrogenic ocular ischemic syndrome and central retinal artery occlusion after receiving a Poly-D, L-lactic acid (PDLLA) filler injection in the nasal region.
What They Found
They found that a patient experienced severe visual loss and ophthalmalgia, diagnosed as iatrogenic ocular ischemic syndrome combined with central retinal artery occlusion, following a PDLLA filler injection. Despite various treatments including ocular massage, intravitreal Aflibercept, and Hyperbaric Oxygen Therapy, the patient's vision remained persistently impaired, marking this as the first reported case of this specific complication.
What This Means for Canadian Patients
Canadian patients considering Poly-D, L-lactic acid (PDLLA) filler injections, particularly in the nasal region, should be aware of the potential for rare but severe ophthalmic complications like vision loss. It is crucial to discuss all potential risks with their healthcare provider and ensure the practitioner has a thorough understanding of facial arterial anatomy.
Canadian Relevance
This study has no direct Canadian connection as it is a case report from outside Canada.
Study Limitations
As a single case report, the findings of this study cannot be generalized to a larger patient population.